573 related articles for article (PubMed ID: 19115316)
1. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G
Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
Csak T; Velayudham A; Hritz I; Petrasek J; Levin I; Lippai D; Catalano D; Mandrekar P; Dolganiuc A; Kurt-Jones E; Szabo G
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G433-41. PubMed ID: 21233280
[TBL] [Abstract][Full Text] [Related]
3. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
Dixon LJ; Berk M; Thapaliya S; Papouchado BG; Feldstein AE
Lab Invest; 2012 May; 92(5):713-23. PubMed ID: 22411067
[TBL] [Abstract][Full Text] [Related]
4. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
[TBL] [Abstract][Full Text] [Related]
5. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
7. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
Yoshida T; Akiba J; Matsui T; Nakamura K; Hisamoto T; Abe M; Ikezono Y; Wada F; Iwamoto H; Nakamura T; Koga H; Yamagishi SI; Torimura T
Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916
[TBL] [Abstract][Full Text] [Related]
8. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Kassel KM; Guo GL; Tawfik O; Luyendyk JP
Lab Invest; 2010 Dec; 90(12):1794-804. PubMed ID: 20697377
[TBL] [Abstract][Full Text] [Related]
9. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.
Marcolin E; San-Miguel B; Vallejo D; Tieppo J; Marroni N; González-Gallego J; Tuñón MJ
J Nutr; 2012 Oct; 142(10):1821-8. PubMed ID: 22915297
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.
Csak T; Bala S; Lippai D; Kodys K; Catalano D; Iracheta-Vellve A; Szabo G
PLoS One; 2015; 10(6):e0129251. PubMed ID: 26042593
[TBL] [Abstract][Full Text] [Related]
11. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis.
Son YJ; Jung DS; Shin JM; Kim M; Yoo G; Nho CW
BMC Complement Med Ther; 2021 Jan; 21(1):44. PubMed ID: 33494735
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
[TBL] [Abstract][Full Text] [Related]
13. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice.
Yamaguchi K; Itoh Y; Yokomizo C; Nishimura T; Niimi T; Fujii H; Okanoue T; Yoshikawa T
Lab Invest; 2010 Aug; 90(8):1169-78. PubMed ID: 20368703
[TBL] [Abstract][Full Text] [Related]
14. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
[TBL] [Abstract][Full Text] [Related]
16. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
[TBL] [Abstract][Full Text] [Related]
17. Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-β-mediated fibrosis.
Zhang C; Zhang B; Chen A; Yin Q; Wang H
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101833. PubMed ID: 34785385
[TBL] [Abstract][Full Text] [Related]
18. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
Ip E; Farrell G; Hall P; Robertson G; Leclercq I
Hepatology; 2004 May; 39(5):1286-96. PubMed ID: 15122757
[TBL] [Abstract][Full Text] [Related]
19. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
Itagaki H; Shimizu K; Morikawa S; Ogawa K; Ezaki T
Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
